GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

Graham Parry, an analyst from Bank of America Securities, maintained the Sell rating on GlaxoSmithKline (GSK – Research Report). The associated ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

Can Harvey Jones aim for a million in his ISA pot by investing in a broad-based portfolio of around 20 FTSE 100 shares, or ...

Tempus AI leverages AI for precision medicine, offering genomics, data services, and AI applications. Click here to read an ...

Jon Smith looks back on some words of wisdom from Warren Buffett about how and where to invest as the market keeps rallying.

GSK’s current market share is around 9% with a nice gap separating ... Furthermore, GSK is well known for providing its brand products with a price in Egypt that can be a fraction of its regular ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2328.55 as on 10 Dec, 2024, 04 ...

GSK PLC - London-based pharmaceuticals firm - Says Dreamm-7 trial shows sustained overall survival benefit for Blenrep, the brand name of belantamab mafodotin, combination versus a daratumumab ...

Me, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In ...